SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Newlink Genetics Corporation
(NASDAQ : NLNK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading NLNK News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-2.25%79.411.6%$919.01m
BIIBBiogen Inc.
0.31%289.931.2%$536.41m
CELGCelgene Corporation
0.86%112.221.1%$518.80m
AMGNAmgen Inc.
0.43%172.021.2%$490.82m
REGNRegeneron Pharmaceuticals, Inc.
3.43%425.123.1%$322.43m
ALXNAlexion Pharmaceuticals, Inc.
-1.38%128.602.6%$246.49m
BMRNBioMarin Pharmaceutical Inc.
1.24%99.423.9%$225.58m
ILMNIllumina, Inc.
-0.04%166.355.1%$194.87m
TSROTESARO, Inc.
-0.41%93.2418.0%$139.38m
VRTXVertex Pharmaceuticals Incorporated
0.82%97.001.7%$134.70m
MDVNMedivation, Inc.
2.40%63.992.6%$121.67m
EXASExact Sciences Corporation
0.35%17.3828.8%$111.63m
JUNOJuno Therapeutics, Inc.
3.41%30.937.9%$107.19m
AAgilent Technologies, Inc.
1.26%48.111.9%$84.25m
INCYIncyte Corporation
2.37%90.212.2%$73.84m

Company Profile

NewLink Genetics Corp. is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications. The company's products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.